Canadian Respiratory Journal
Volume 2019 (2019), Article ID 5906984, 1 page
https://doi.org/10.1155/2019/5906984

Corrigendum

Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”

Nguyen Xuan Thanh,¹ Philip Jacobs,² Jason Suggett,³ Andrew McIvor,⁴ and Alan Kaplan⁵

¹School of Public Health, University of Alberta, Edmonton, Alberta, Canada
²Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
³Trudell Medical International, London, Ontario, Canada
⁴McMaster University, Hamilton, Ontario, Canada
⁵Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada

Correspondence should be addressed to Nguyen Xuan Thanh; tnguyen@ualberta.ca

Received 17 March 2019; Accepted 18 March 2019; Published 19 May 2019

Copyright © 2019 Nguyen Xuan Thanh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled, “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada” [1], the affiliation of the first author was incorrect. Also, the e-mail address of the first/corresponding author has been updated. The corrected authors’ list and affiliations are shown above.

References

N. X. Thanh, P. Jacobs, J. Suggett, A. McIvor, and A. Kaplan, “Cost-effectiveness of the Aerobika® oscillating positive expiratory pressure device in the management of chronic obstructive pulmonary disease exacerbations in Canada,” Canadian Respiratory Journal, vol. 2019, Article ID 9176504, 7 pages, 2019.